You picked a gel because a daily rub-on felt easier than a needle. Fair. But a topical hormone does not stay politely on your skin, and if you have young kids climbing on you every night, transfer is the one safety detail worth understanding before you start.
Why transfer happens at all
Topical testosterone is designed to cross skin. That is the whole point: the gel dries, and the hormone absorbs through the outer layer over hours [1]. The catch is that skin does not know whose skin it is touching. Wherever your treated shoulder, upper arm, or abdomen presses against another person, some of that testosterone can move onto them. This is called secondary exposure, and it is well documented enough that the U.S. Food and Drug Administration required a boxed warning, its most serious warning, on approved testosterone gels specifically about transfer to women and children [2].
For a 44-year-old with a couch full of kids by nine, or a 34-year-old whose fiancee shares the same bed and towels, this is not a fringe concern. It is a normal, manageable part of using a topical, and it is one of the first things an independent provider walks through.
What the transfer warning actually describes
The FDA's warning is not vague. Reported cases in children exposed to testosterone gels have included signs of early puberty: enlarged genitals, pubic hair, increased bone age, aggressive behavior, and increased libido [2][3]. In most reported pediatric cases, signs regressed after the child stopped being exposed to the medication, though bone-age changes did not always fully reverse [3]. In women, reported effects have included acne and unwanted hair growth [2].
The important framing: these are reports tied to skin-to-skin contact and untreated application sites, not an inevitable outcome of you using a gel correctly. The risk is real, and it is also largely controllable with a handful of habits.
Source: [2] FDA Drug Safety Communication: Testosterone gel and children exposure, [3] Secondary Exposure to Testosterone Gel: Signs of Virilization in Children (PubMed)
The habits an independent provider explains
Product labeling for approved topical testosterone lays out concrete precautions, and an independent provider typically reviews these with you before anything is prescribed [1][4]:
- Wash your hands with soap and water right after applying.
- Cover the application site with clothing once the gel has dried.
- Wash the site before any skin-to-skin contact with another person is anticipated.
- Keep the site off-limits to kids and partners; no leaning a toddler's face against a freshly treated shoulder.
- Mind shared surfaces: towels, sheets, and your own hands are the usual transfer routes.
Timing matters too. Labeling directs users to apply to specific covered areas (such as the shoulders and upper arms for some products, the abdomen for others) precisely because those spots are easy to cover and keep away from a child's reach [1][4]. The exact site, product, and timing are decisions an independent licensed provider makes for you, not something to improvise from an article.
The shower-and-bedtime reality for a dad
Here is where real life meets the label. If your kids pile onto you after dinner, the practical questions become: is the site dry, is it covered, and have you washed your hands? Some men time application so the site is dry and covered well before the evening crush, or shower and re-cover before close contact. These are exactly the logistics a provider helps you sequence around your household, and they are a legitimate reason some men consider an injectable instead. Neither route is automatically "safer"; they carry different tradeoffs, and that conversation belongs with your provider.
Source: [1] AndroGel (testosterone gel) Prescribing Information, FDA Label, [4] Testim (testosterone gel) Prescribing Information, FDA Label
Injections don't transfer, but they raise a different question
If transfer risk is a dealbreaker because of small kids, an injection sidesteps the skin-contact problem entirely. But for a younger man planning a family, there is a separate issue worth naming honestly: standard testosterone therapy, whether gel or injection, can suppress the body's own signaling and lower sperm production. Exogenous testosterone reduces the pituitary hormones (LH and FSH) that drive the testes, and this can impair fertility [5][6]. The Endocrine Society is explicit that clinicians should not prescribe testosterone to men who are planning fertility in the near term, and should discuss fertility-preserving alternatives [6].
So the two concerns split by life stage. For the dad with young kids already, transfer is the front-of-mind safety detail. For the founder a year from starting a family, the bigger question is whether standard testosterone is even the right tool right now, or whether a fertility-sparing path deserves a real conversation with a provider who treats that goal as non-negotiable.
Confirming the problem before choosing a delivery method
Before any of this matters, the diagnosis has to be solid. The Endocrine Society recommends diagnosing low testosterone only in men with consistent symptoms and unequivocally low testosterone measured on morning blood samples, on at least two separate occasions [6]. Testosterone follows a daily rhythm and varies day to day, so a single midday draw is a weak basis for a lifelong decision. A "low normal" result with a shrug is often a reason to retest properly in the morning, not a closed door.
This is educational information, not medical advice. Whether topical or injectable testosterone is appropriate for you, and how to manage transfer or fertility, is a decision only an independent licensed provider can make after reviewing your labs and history.
Source: [6] Testosterone Therapy in Men With Hypogonadism: Endocrine Society Clinical Practice Guideline
Where Velri fits
Velri is a technology and coordination company. It does not provide medical care. What Velri does is streamline the parts that usually stall out: coordinating lab work so your testosterone is measured properly, connecting you with an independent, physician-led Provider Group for an evaluation, and, if a provider decides treatment is appropriate, coordinating with an independent licensed pharmacy to fill what is prescribed.
A prescription is never guaranteed. The Velri clinical review process exists so an independent provider can weigh your symptoms, your morning labs, your household, and your goals (including fertility) before anything is decided. If a compounded medication is ever part of that plan, note: compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state. Velri's care coordination starts in Nevada, with more states rolling out.
